PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS)

Release Date: June 24, 2025

Expiration Date: June 24, 2026

Thanks for your interest in this podcast. Please read this important program information before listening.

Episode Description

In this podcast, ALS expert Terry Heiman-Patterson, MD, discusses best practices for ALS diagnosis and use of targeted therapy.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Apply recommended diagnostic criteria and strategies to make an early, accurate diagnosis of ALS
• Discuss the mechanisms of action, efficacy, and safety of approved and emerging treatments for patients with ALS

Instructions on How to Receive Credit

1. Listen to this podcast in its entirety.
2. Go to gotoper.com/credit and enter code: 6322
3. Answer the evaluation questions.
4. Request credit using the drop-down menu.

You may immediately download your certificate.

Faculty, Staff, and Planners' Disclosures

In accordance with ACCME Guidelines, PER^® has identified and resolved all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible companies.

This podcast was developed by PER^® editorial staff based on an online activity developed with these faculty.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.